Today: 20 March 2026
Browse Category

NASDAQ:SNDL 4 November 2025 - 15 December 2025

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Brands shares surged December 15 as global cannabis stocks rallied on reports that Donald Trump may push to reclassify marijuana as a Schedule III drug. The move, which would ease federal restrictions but stop short of legalization, fueled investor optimism over potential tax and banking benefits for the industry. Tilray also completed a 1-for-10 reverse stock split and reported momentum in its Canadian portfolio.
SNDL Stock Jumps on Marijuana Rescheduling Headlines: Latest News (Dec. 12, 2025), Forecasts, and What Investors Are Watching

SNDL Stock Jumps on Marijuana Rescheduling Headlines: Latest News (Dec. 12, 2025), Forecasts, and What Investors Are Watching

SNDL Inc. shares rose sharply Friday after reports that the Trump administration may seek to reclassify marijuana as a Schedule III drug. The Washington Post and Reuters said no final decision has been made, but the move could ease research restrictions and improve industry economics. SNDL was among the top cannabis gainers in premarket trading.
12 December 2025
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. shares fell 12% to $1.93 on Nov. 4 after reporting a Q3 net loss of C$11.1 million despite record free cash flow and 3.1% revenue growth to C$244.2 million. The stock is up about 10% year-to-date but down nearly 15% in the past month. SNDL holds C$240.6 million in cash and no debt. Analyst consensus remains “Hold” with a $2.50 price target.

Stock Market Today

  • Schwab Fundamental International Large Company Index Sees $218.8M Inflow
    March 20, 2026, 11:42 AM EDT. The Schwab Fundamental International Large Company Index ETF (FNDF) experienced a notable inflow of approximately $218.8 million, marking a 1.0% increase in outstanding units week over week, rising from 442.3 million to 446.8 million units. Major holdings performance varied slightly, with Medtronic (MDT) and ZIM Integrated Shipping Services (ZIM) gaining 0.2% each, while Teva Pharmaceutical (TEVA) fell 1.8%. FNDF currently trades at $47.66, between its 52-week low of $31.915 and high of $52.935. ETF unit creation and destruction reflect buying and selling of underlying assets, influencing components' market activity.
Go toTop